Open Access

Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases

  • Authors:
    • Yuanliang Wang
    • Guobiao Liang
    • Jing Tian
    • Xin Wang
    • Anjian Chen
    • Tiancai Liang
    • Yang Du
    • Hao Li
    • Jiang Du
    • Lang Yu
    • Zongping Chen
  • View Affiliations

  • Published online on: February 5, 2018     https://doi.org/10.3892/ol.2018.7957
  • Pages: 4882-4890
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The objective of the present study was to systematically investigate the clinical features, diagnosis and therapeutic treatment of Von Hippel‑Lindau (VHL) syndrome in order to improve understanding of this disease. A total of 3 cases of VHL syndrome treated at the Affiliated Hospital of Zunyi Medical College (Zunyi, China) between September 2014 and October 2015 were retrospectively analyzed. The associated literature was reviewed, and the diagnostic and therapeutic features were discussed. Case 1 was diagnosed as VHL syndrome accompanied by a renal tumor on the right side, and radical tumor resection in the right kidney was performed. Postoperative pathological examination indicated clear cell carcinoma. Case 2 was diagnosed as VHL syndrome accompanied by bilateral adrenal pheochromocytoma. The left‑side adrenal tumor was removed, and postoperative pathological analysis was suggestive of adrenal pheochromocytoma. Case 3 visited the hospital due to the presence of masses on the left and right sides of the kidney, but did not undergo surgery for personal reasons. Follow‑ups were scheduled subsequent to surgery at another hospital. The diagnosis in all 3 cases was confirmed by genetic testing, where VHL mutations were detected in all patients. Following surgery, pedigree and genetic analysis was performed in all 3 pedigrees and VHL mutations were identified in 7 family members. The diagnosis of VHL syndrome should be based on the clinical manifestation of the patients and the results of genetic tests. DNA analysis of mutations is the main method for diagnosis. An appropriate surgical plan should be formulated based on the site, size and number of tumors, and the condition of the patient. Since VHL syndrome is an inheritable genetic disorder and relapse following surgery is common, pedigree analysis of the patient and lifelong follow‑ups are essential. Additionally, physicians should pay attention to VHL syndrome in order to avoid missing diagnosis or misdiagnosis.

References

1 

Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: von Hippel-Lindau disease. Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Shuin T, Yamazaki I, Tamura K, Kamada M and Ashida S: Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease. Int J Clin Oncol. 9:283–287. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI

4 

Kim W and Kaelin WG Jr: The von Hippel-Lindau tumor suppressor protein: New insights into oxygen sensing and cancer. Curr Opin Genet Dev. 13:55–60. 2003. View Article : Google Scholar : PubMed/NCBI

5 

McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F and Maher ER: Genotype-phenotype correlations in VHL exon deletions. Am J Med Genet A. 149A:2147–2151. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, et al: Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol. 23:2763–2771. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR and Blute ML: A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: A stratification tool for prospective clinical trials. J Urol. 174:1759–1763. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Vortmeyer AO, Choo D, Pack S, Oldfield E and Zhuang Z: VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology. 55:4602000. View Article : Google Scholar : PubMed/NCBI

9 

Neumann HP and Wiestler OD: Clustering of features of von Hippel-Lindau syndrome: Evidence for a complex genetic locus. Lancet. 337:1052–1054. 1991. View Article : Google Scholar : PubMed/NCBI

10 

Weil RJ, Vortmeyer AO, Zhuang Z, Pack SD, Theodore N, Erickson RK and Oldfield EH: Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. J Neurosurg. 96:775–787. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Kanno H, Yamamoto I, Yoshida M and Kitamura H: Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease. Neurology. 60:1197–1199. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Hayden MG, Gephart R, Kalanithi P and Chou D: Von Hippel-Lindau disease in pregnancy: A brief review. J Clin Neurosci. 16:611–613. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Bader HL and Hsu T: Systemic VHL gene functions and the VHL disease. FEBS Lett. 586:1562–1569. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Maher ER, Neumann HP and Richard S: von Hippel-Lindau disease: A clinical and scientific review. Eur J Hum Genet. 19:617–623. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Glasker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J and Neumann HP: The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 67:758–762. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM and Rigamonti D: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 48:55–63. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM and Bratslavsky G: Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol. 184:1855–1859. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM and Walther MM: The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 172:63–65. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Esrig D, Richie JP, deKernion JB, et al: Treatment of renal cell carcinoma in von Hippel-Lindau disease: A multicenter study. J Urol. 153:1812–1816. 1995. View Article : Google Scholar : PubMed/NCBI

20 

Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H and Blute ML: Renal cell carcinoma in the solitary kidney: An analysis of complications and outcome after nephron sparing surgery. J Urol. 168:454–459. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Albers P: Treatment approaches in renal cell carcinoma: past, present and future perspectives. Eur Urol Suppl. 7:36–45. 2008. View Article : Google Scholar

22 

Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S and Benoit G: Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology. 70:435–439. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Linehan WM, Rubin JS and Bottaro DP: VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol. 41:753–756. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Roupret M, Hopirtean V, Mejean A, Thiounn N, Dufour B, Chretien Y, Chauveau D and Richard S: Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: A single center experience. J Urol. 170:1752–1755. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Marcos HB, Libutti SK, Alexander HR, Lubensky IA, Bartlett DL, Walther MM, Linehan WM, Glenn GM and Choyke PL: Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: Spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology. 225:751–758. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Frantzen C, Links T and Giles R: Von Hippel-Lindau Disease. Seattle (WA); University of Washington, Seattle: 2000

27 

Jia D, Tang B, Shi Y, Wang J, Sun Z, Chen Z, Zhang L, Xia K and Jiang H: A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease. J Clin Neurosci. 20:842–847. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, et al: Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 3:1303–1308. 1994. View Article : Google Scholar : PubMed/NCBI

29 

Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Höfler H, Latif F, Lerman MI, Zbar B and Neumann HP: Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: Evidence for a founder effect. Hum Genet. 95:551–556. 1995. View Article : Google Scholar : PubMed/NCBI

30 

Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, et al: Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat. 8:348–357. 1996. View Article : Google Scholar : PubMed/NCBI

31 

Siu WK, Ma RC, Lam CW, Mak CM, Yuen YP, Lo FM, Chan KW, Lam SF, Ling SC, Tong SF, et al: Molecular basis of von Hippel-Lindau syndrome in Chinese patients. Chin Med J (Engl). 124:237–241. 2011.PubMed/NCBI

32 

Hes FJ, van der Luijt RB, Janssen AL, Zewald RA, de Jong GJ, Lenders JW, Links TP, Luyten GP, Sijmons RH, Eussen HJ, et al: Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification. Clin Genet. 72:122–129. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Ciotti P, Garuti A, Gulli R, Ballestrero A, Bellone E and Mandich P: Germline mutations in the von Hippel-Lindau gene in Italian patients. Eur J Med Genet. 52:311–314. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y., Liang, G., Tian, J., Wang, X., Chen, A., Liang, T. ... Chen, Z. (2018). Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases. Oncology Letters, 15, 4882-4890. https://doi.org/10.3892/ol.2018.7957
MLA
Wang, Y., Liang, G., Tian, J., Wang, X., Chen, A., Liang, T., Du, Y., Li, H., Du, J., Yu, L., Chen, Z."Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases". Oncology Letters 15.4 (2018): 4882-4890.
Chicago
Wang, Y., Liang, G., Tian, J., Wang, X., Chen, A., Liang, T., Du, Y., Li, H., Du, J., Yu, L., Chen, Z."Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases". Oncology Letters 15, no. 4 (2018): 4882-4890. https://doi.org/10.3892/ol.2018.7957